Combination therapy holds promise, however further studies are needed to define optimal treatment strategies
One of the most common is prior authorization, a process that requires your doctor to get pre-approval from the insurer
however, companies like Hims and Hers might have to stop selling compounded versions of the drugs
In the Phase 3 TRIUMPH-1 obesity trial, patients on the highest dose lost an average of 70.3 pounds, or 28.3% of body weight, over 80 weeks
This case demonstrates the effectiveness of a tailored, stepwise treatment in reversing the aesthetic consequences of medically-induced weight loss, providing both functional and emotional benefit to the patient
Saxenda is the medication alone